DK1173437T3 - Thiazolidinindionderivat og dets anvendelse som antidiabetisk middel - Google Patents

Thiazolidinindionderivat og dets anvendelse som antidiabetisk middel

Info

Publication number
DK1173437T3
DK1173437T3 DK00920895T DK00920895T DK1173437T3 DK 1173437 T3 DK1173437 T3 DK 1173437T3 DK 00920895 T DK00920895 T DK 00920895T DK 00920895 T DK00920895 T DK 00920895T DK 1173437 T3 DK1173437 T3 DK 1173437T3
Authority
DK
Denmark
Prior art keywords
indione
thiazolidine
derivative
antidiabetic agent
antidiabetic
Prior art date
Application number
DK00920895T
Other languages
Danish (da)
English (en)
Inventor
Paul David James Blackler
Andrew Simon Craig
Robert Gordon Giles
Michael John Sasse
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of DK1173437T3 publication Critical patent/DK1173437T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK00920895T 1999-04-20 2000-04-19 Thiazolidinindionderivat og dets anvendelse som antidiabetisk middel DK1173437T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9909075.5A GB9909075D0 (en) 1999-04-20 1999-04-20 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
DK1173437T3 true DK1173437T3 (da) 2004-07-12

Family

ID=10851922

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00920895T DK1173437T3 (da) 1999-04-20 2000-04-19 Thiazolidinindionderivat og dets anvendelse som antidiabetisk middel

Country Status (42)

Country Link
EP (2) EP1411054A1 (fr)
JP (2) JP4283450B2 (fr)
KR (1) KR100677815B1 (fr)
CN (2) CN101125851A (fr)
AP (1) AP1680A (fr)
AR (2) AR023563A1 (fr)
AT (1) ATE262524T1 (fr)
AU (1) AU773112B2 (fr)
BG (1) BG65428B1 (fr)
BR (1) BR0009898A (fr)
CA (1) CA2370270A1 (fr)
CO (1) CO5170420A1 (fr)
CZ (1) CZ300934B6 (fr)
DE (1) DE60009276T2 (fr)
DK (1) DK1173437T3 (fr)
DZ (1) DZ3163A1 (fr)
EA (1) EA004769B1 (fr)
EG (1) EG23946A (fr)
ES (1) ES2214267T3 (fr)
GB (1) GB9909075D0 (fr)
HK (1) HK1045304B (fr)
HR (1) HRP20010771B1 (fr)
HU (1) HUP0200785A3 (fr)
IL (1) IL146077A0 (fr)
MA (1) MA26784A1 (fr)
MX (1) MXPA01010695A (fr)
MY (1) MY125209A (fr)
NO (1) NO320573B1 (fr)
NZ (1) NZ515164A (fr)
OA (1) OA11867A (fr)
PE (1) PE20010047A1 (fr)
PL (1) PL351115A1 (fr)
PT (1) PT1173437E (fr)
RS (1) RS50137B (fr)
SI (1) SI1173437T1 (fr)
SK (1) SK284990B6 (fr)
TR (1) TR200103041T2 (fr)
TW (1) TWI291463B (fr)
UA (1) UA72245C2 (fr)
UY (1) UY26113A1 (fr)
WO (1) WO2000063206A2 (fr)
ZA (1) ZA200108721B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9909075D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical
GB0006133D0 (en) 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical
GB0014005D0 (en) * 2000-06-08 2000-08-02 Smithkline Beecham Plc Novel pharmaceutical
CN100390170C (zh) * 2001-11-21 2008-05-28 史密斯克莱·比奇曼公司 5-(4-(2-(n-甲基-n-(2-吡啶基)氨基)乙氧基)苄基)噻唑烷-2,4-二酮苯磺酸盐,它的制备方法,其多晶型物ⅰ、ⅱ和ⅲ和它作为药物活性成分的用途
KR100450700B1 (ko) * 2002-03-22 2004-10-01 주식회사종근당 티아졸리딘디온 유도체 화합물 및 이를 함유하는 약제학적조성물
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
EP1842850A1 (fr) * 2006-03-23 2007-10-10 Sandoz AG Rosiglitazone hydrochlorid hemihydrat

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE186724T1 (de) * 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9909075D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
MXPA01010695A (es) 2002-06-04
DZ3163A1 (fr) 2000-10-26
SK14892001A3 (sk) 2002-02-05
DE60009276T2 (de) 2004-08-26
PT1173437E (pt) 2004-06-30
CZ300934B6 (cs) 2009-09-16
AR023563A1 (es) 2002-09-04
JP4283450B2 (ja) 2009-06-24
CN101125851A (zh) 2008-02-20
BG65428B1 (bg) 2008-07-31
EP1173437B1 (fr) 2004-03-24
HK1045304B (zh) 2004-12-24
WO2000063206A2 (fr) 2000-10-26
ZA200108721B (en) 2002-09-13
AP2001002332A0 (en) 2001-12-31
MA26784A1 (fr) 2004-12-20
JP2009161544A (ja) 2009-07-23
PL351115A1 (en) 2003-03-24
YU81601A (sh) 2004-09-03
GB9909075D0 (en) 1999-06-16
NZ515164A (en) 2004-02-27
SI1173437T1 (en) 2004-06-30
HRP20010771B1 (en) 2005-06-30
EA004769B1 (ru) 2004-08-26
AU773112B2 (en) 2004-05-20
CA2370270A1 (fr) 2000-10-26
AP1680A (en) 2006-11-27
NO20015105D0 (no) 2001-10-19
CN1327446A (zh) 2001-12-19
UY26113A1 (es) 2000-12-29
KR20010112446A (ko) 2001-12-20
BR0009898A (pt) 2002-04-16
AR023567A1 (es) 2002-09-04
CO5170420A1 (es) 2002-06-27
HK1045304A1 (en) 2002-11-22
HUP0200785A3 (en) 2004-03-29
IL146077A0 (en) 2002-07-25
JP2002542243A (ja) 2002-12-10
NO20015105L (no) 2001-12-19
EA200101102A1 (ru) 2002-04-25
OA11867A (en) 2006-03-02
CZ20013758A3 (cs) 2003-05-14
PE20010047A1 (es) 2001-03-10
SK284990B6 (sk) 2006-04-06
NO320573B1 (no) 2005-12-27
EG23946A (en) 2008-01-22
EP1173437A2 (fr) 2002-01-23
MY125209A (en) 2006-07-31
UA72245C2 (uk) 2005-02-15
AU4131100A (en) 2000-11-02
KR100677815B1 (ko) 2007-02-05
RS50137B (sr) 2009-03-25
HUP0200785A2 (en) 2002-08-28
DE60009276D1 (de) 2004-04-29
BG106120A (en) 2002-05-31
EP1411054A1 (fr) 2004-04-21
TR200103041T2 (tr) 2002-03-21
ATE262524T1 (de) 2004-04-15
WO2000063206A3 (fr) 2001-02-22
TWI291463B (en) 2007-12-21
ES2214267T3 (es) 2004-09-16
HRP20010771A2 (en) 2002-12-31

Similar Documents

Publication Publication Date Title
DK1173434T3 (da) Thiazolidindionderivat og dets anvendelse som antidiabetisk middel
NO20020383D0 (no) Mutilinderivater og deres anvendelse som anti-bakterielle midler
NO20020683L (no) Arylmetyl karbonylamino tiazolderivater og deres anvendelse som antitumormidler
NO20021408L (no) Oksa- og tiadiazol-derivater anvendelige som antidiabetiske og antiovervektsmidler
NO20021253L (no) Kinolylpropylpiperidinderivater og deres anvendelse som antibakterielle midler
DK1216247T3 (da) Imidazoimidazoler og triazoler som anti-inflammatoriske midler
IS6385A (is) Ný notkun og nýjar N-asabísýkló-amíð afleiður
NO20025978L (no) Benzotiazol-derivater
DK1362027T3 (da) Acylerede 6,7,8,9-tetrahydro-5H-benzocycloheptenylaminer og deres anvendelse som farmaceutisk middel
DK1478629T3 (da) N-aryl-2-oxazolidinon-5-carboxamider og deres derivater og deres anvendelse som antibakterielle midler
HK1045152A1 (zh) 噻唑烷二酮衍生物及其用作抗糖尿病藥的應用
NO20001905L (no) (Poly)tiaalkynforbindelser og deres derivater, preparater omfattende disse og deres anvendelse
DK1231211T3 (da) Thiazolidindion-derivater som antidiabetika
DK1173437T3 (da) Thiazolidinindionderivat og dets anvendelse som antidiabetisk middel
DK1173436T3 (da) Thiazolidindionderivat og anvendelse deraf som antidiabetikum
NO20030998L (no) Arylpiperazinderivater og deres anvendelse som psykotropiske midler
NO20021612D0 (no) Karbonylstressreduserende middel
DK1325000T3 (da) Thiazoldiendionderivat og dets anvendelse som antidiabetisk middel
NO20035652L (no) Tiaziner og tiazoler som materialbeskyttelsesmidler
ES1049399Y (es) Figura articulada perfeccionada.
NO20005909D0 (no) Soppbasert middel samt fremstilling og anvendelse av dette
DK1131061T3 (da) Prolactin-sænkkende middel
NO20014300D0 (no) Nytt protein og dets anvendelse